The High Impact of Penicillin Allergy Registration in Hospitalized Patients

Journal of Allergy and Clinical Immunology: In Practice

Volumn 4, Issue 5, 2016, Pages 926-931

  van Dijk, Savannah M ^a   Gardarsdottir, Helga ^a   Wassenberg, Marjan W M ^a   Oosterheert, Jan Jelrik ^a   de Groot, Mark C H ^a   Rockmann, Heike ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Allergy registration; Antimicrobial stewardship; Beta lactam antibiotic; Drug hypersensitivity; Penicillin

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FLUCLOXACILLIN; LINCOSAMIDE; MACROLIDE; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN DERIVATIVE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENDER; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; PENICILLIN ALLERGY; PREVALENCE; PROSPECTIVE STUDY; REGISTER; DRUG HYPERSENSITIVITY; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; UNIVERSITY HOSPITAL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG HYPERSENSITIVITY; FEMALE; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PENICILLINS; PROSPECTIVE STUDIES;

EID: 84964592914     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2016.03.009     Document Type: Article

References (41)

1. 1 Hulscher, M.E., Grol, R.P., van der Meer, J.W., Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 10 (2010), 167–175.
2. 2 Cars, O., Molstad, S., Melander, A., Variation in antibiotic use in the European Union. Lancet 357 (2001), 1851–1853.
3. 3 Griens AMGF, Janssen JM, Kroon JDL, Lukaart JS, van der Vaart RJ. Data en feiten 2014. Het jaar 2013 in cijfers. Stichting Farmaceutische Kengetallen. 2014. Available from: http://www.sfk.nl/nieuws-publicaties/data-en-feiten/SFKDataenfeiten2014.pdf. Accessed August 1, 2015.
4. 4 Sade, K., Holtzer, I., Levo, Y., Kivity, S., The economic burden of antibiotic treatment of penicillin-allergic patients in internal medicine wards of a general tertiary care hospital. Clin Exp Allergy 33 (2003), 501–506.
5. 5 Macy, E., Contreras, R., Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J Allergy Clin Immunol 133 (2014), 790–796.
6. 6 Solensky, R., Hypersensitivity reactions to beta-lactam antibiotics. Clin Rev Allergy Immunol 24 (2003), 201–220.
7. 7 Satta, G., Hill, V., Lanzman, M., Balakrishnan, I., Beta-lactam allergy: clinical implications and costs. Clin Mol Allergy, 11, 2013, 2.
8. 8 Li, M., Krishna, M.T., Razaq, S., Pillay, D., A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of ‘penicillin allergy’ in a UK teaching hospital. J Clin Pathol 67 (2014), 1088–1092.
9. 9 Borch, J.E., Andersen, K.E., Bindslev-Jensen, C., The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population. Basic Clin Pharmacol Toxicol 98 (2006), 357–362.
10. 10 MacLaughlin, E.J., Saseen, J.J., Malone, D.C., Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergy. Arch Fam Med 9 (2000), 722–726.
11. 11 Lee, C.E., Zembower, T.R., Fotis, M.A., Postelnick, M.J., Greenberger, P.A., Peterson, L.R., et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med 160 (2000), 2819–2822.
12. 12 Charneski, L., Deshpande, G., Weiss Smith, S., Impact of an antimicrobial allergy label in the medical record on clinical outcomes in hospitalized patients. Pharmacotherapy 31 (2011), 742–747.
13. 13 Salden, O.A.E., Rockmann, H., Verheij, T.J.M., Broekhuizen, B.D.L., Diagnosis of allergy against beta-lactams in primary care: prevalence and diagnostic criteria. Fam Pract 32 (2015), 257–262.
14. 14 Kerr, J.R., Penicillin allergy: a study of incidence as reported by patients. Br J Clin Pract 48 (1994), 5–7.
15. 15 Bousquet, P.J., Pipet, A., Bousquet-Rouanet, L., Demoly, P., Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy 38 (2008), 185–190.
16. 16 Gamboa, P.M., The epidemiology of drug allergy-related consultations in Spanish Allergology services: Alergológica-2005. J Investig Allergol Clin Immunol 19 (2009), 45–50.
17. 17 Doña, I., Blanca-López, N., Torres, M.J., García-Campos, J., García-Núñez, I., Gómez, F., et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 22 (2012), 363–371.
18. 18 García Núñez, I., Barasona Villarejo, M.J., Algaba Mármol, M.A., Moreno Aguilar, C., Guerra Pasadas, F., Diagnosis of patients with immediate hypersensitivity to beta-lactams using retest. J Investiga Allergol Clin Immunol 22 (2012), 41–47.
19. 19 Hjortlund, J., Mortz, C.G., Skov, P.S., Bindslev-Jensen, C., Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy 68 (2013), 1057–1064.
20. 20 Kopac, P., Zidarn, M., Kosnik, M., Epidemiology of hypersensitivity reactions to penicillin in Slovenia. Acta Dermatovenerol Alp Pannonica Adriat 21 (2012), 65–67.
21. 21 Macy, E., Nqor, E.W., Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. J Allergy Clin Immunol Pract 1 (2013), 258–263.
22. 22 Ferré-Ybarz, L., Salinas Argente, R., Gómez Galán, C., Duocastella Selvas, P., Nevot Falcó, S., Analysis of profitability in the diagnosis of allergy to beta-lactam antibiotics. Allergol Immunopathol (Madr) 43 (2015), 369–375.
23. 23 Ponvert, C., Perrin, Y., Bados-Albiero, A., Le Bourgeois, M., Karila, C., Delacourt, C., et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol 22 (2011), 411–418.
24. 24 Zambonino, M.A., Corzo, J.L., Muñoz, C., Requena, G., Ariza, A., Mayorga, C., et al. Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children. Pediatr Allergy immunol 25 (2014), 80–87.
25. 25 Unger, N.R., Gauthier, T.P., Cheung, L.W., Penicillin skin testing: potential implications for antimicrobial stewardship. Pharmacotherapy 33 (2013), 856–867.
26. 26 McCaig, L.F., Hughes, J.M., Trends in antimicrobial drug prescribing among office-based physicians in the United States. J Am Med Assoc 273 (1995), 214–219.
27. 27 Kim, S.H., Kim, K.H., Kim, H.B., Kim, N.J., Kim, E.C., Oh, M.D., et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 52 (2008), 192–197.
28. 28 Classen, D.C., Pestotnik, S.L., Evans, R.S., Lloyd, J.F., Burke, J.P., Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. J Am Med Assoc 277 (1997), 301–306.
29. 29 Raja, A.S., Lindsell, C.J., Bernstein, J.A., Codispoti, C.D., Moellman, J.J., The use of penicillin skin testing to assess the prevalence of penicillin allergy in an emergency department setting. Ann Emerg Med 54 (2009), 72–77.
30. 30 ten Berg, M.J., Huisman, A., van den Bemt, P.M., Schobben, A.F., Egberts, A.C., van Solinge, W.W., Linking laboratory and medication data: new opportunities for pharmacoepidemiological research. Clin Chem Lab Med 45 (2007), 13–19.
31. 31 WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2015, Oslo. 2015. Available from: http://www.whocc.no/filearchive/publications/2015_guidelines.pdf. Accessed November 26, 2015.
32. 32 Prins, J.M., Kullberg, B.J., Gyssens, I.C., National guidelines for the use of antibiotics in hospitalised adult patients: the SWAB guidelines revisited. Neth J Med 63 (2005), 288–290.
33. 33 Bronzwaer, S.L., Cars, O., Buchholz, U., Molstad, S., Goettsch, W., Veldhuijzen, I.K., et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8 (2002), 278–282.
34. 34 Goossens, H., Ferech, M., Coenen, S., Stephens, P., European Surveillance of Antimicrobial Consumption Project Group. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis 44 (2007), 1091–1095.
35. 35 Pablos, A.I., Escobar, I., Albinana, S., Serrano, O., Ferrari, J.M., Herreros de Tejada, A., Evaluation of an antibiotic intravenous to oral sequential therapy program. Pharmacoepidemiol Drug Saf 14 (2005), 53–59.
36. 36 Macy, E., Contreras, R., Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis. J Allergy Clin Immunol 135 (2015), 745–752.e5.
37. 37 TESSy, The European Surveillance System. Proportion of methicillin resistant Staphylococcus aureus (MRSA) isolates in participating countries in 2013. 2013. Available from: http://ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/map_reports.aspx. Accessed October 10, 2015.
38. 38 Thomas, J., Coralic, A., Ruegger, M., Thompson-Moore, N., Descriptive analysis of patient readmissions within 60 days due to medication-related events. Hosp Pharm 50 (2015), 595–602.
39. 39 de Kraker, M.E., Wolkewitz, M., Davey, P.G., Koller, W., Berger, J., Nagler, J., et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 66 (2011), 398–407.
40. 40 Picard, M., Begin, P., Bouchard, H., Cloutier, J., Lacombe-Barrios, J., Paradis, J., et al. Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital. J Allergy Clin Immunol Pract 1 (2013), 252–257.
41. 41 Rimawi, R.H., Cook, P.P., Gooch, M., Kabchi, B., Ashraf, M.S., Rimawi, B.H., et al. The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. J Hosp Med 8 (2013), 341–345.